Ionis Pharmaceuticals Inc
NASDAQ:IONS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
Doximity Inc
NYSE:DOCS
|
US |
|
Tempest Therapeutics Inc
NASDAQ:TPST
|
US |
|
Constellation Energy Corp
NASDAQ:CEG
|
US |
|
Bank Sankt-Peterburg PAO
MOEX:BSPB
|
RU |
|
EFORT Intelligent Equipment Co Ltd
SSE:688165
|
CN |
|
Turvo International Co Ltd
TWSE:2233
|
TW |
|
S
|
SGA Solutions Co Ltd
KOSDAQ:184230
|
KR |
|
Castle Minerals Ltd
ASX:CDT
|
AU |
|
Sunflag Iron and Steel Co Ltd
NSE:SUNFLAG
|
IN |
|
Wild Bunch AG
F:WBAH
|
DE |
|
Sadhana Nitro Chem Ltd
BSE:506642
|
IN |
|
Aethlon Medical Inc
NASDAQ:AEMD
|
US |
Wall Street
Price Targets
IONS Price Targets Summary
Ionis Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
IONS
is 94.3 USD
with a low forecast of 46.46 USD and a high forecast of 115.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IONS's stock price target?
Price Target
94.3
USD
According to Wall Street analysts, the average 1-year price target for
IONS
is 94.3 USD
with a low forecast of 46.46 USD and a high forecast of 115.5 USD.
What is Ionis Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
26%
For the last 14 years the
compound annual growth rate for
Ionis Pharmaceuticals Inc's revenue is
17%.
The projected
CAGR
for the next 3 years is
26%.